PROGRAM CHAIR

Brad Dickerson, MD, MMSc, FAAN
Director, Frontotemporal Disorders Unit
Massachusetts General Hospital
Professor of Neurology
Harvard Medical School
Boston, MA

FACULTY PRESENTER
Marc Agronin, MD
Chief Medical Officer
Frank C. and Lynn Scaduto MIND Institute and Behavioral Health
Miami Jewish Health
Miami, FL

PROGRAM OVERVIEW
This interactive TeleECHO program is designed to provide clinicians who manage patients with Alzheimer’s disease (AD) with up-to-date information on the early diagnosis and treatment in these patients, using strategies to address stigma, apply quantitative assessments, and integrate neuroimaging in clinical assessment; optimal multidisciplinary communication and specialty referral; integration of clinical data updates to inform early identification of AD; and shared decision-making (SDM) approaches with patients and caregivers to facilitate diagnosis and optimize care plans.  

TARGET AUDIENCE
This activity is designed to meet the educational needs of healthcare providers (HCPs) involved in the diagnosis and continued care of patients with AD, including neurologists, geriatricians, psychiatrists, primary care physicians, nurses, and other multidisciplinary team members. It is important to reach both community HCPs and specialists given the coordinated effort required for the diagnosis and management of patients with AD.

LEARNING OBJECTIVES
Learning objectives: Upon completion of 1 or more of the proposed activities and using the resources provided, HCPs will have improved ability to:

• Implement strategies to overcome barriers to timely diagnosis of AD, addressing stigma, applying quantitative assessments, and integrating neuroimaging as well as specialty referral in clinical assessment
• Formulate strategies to optimize multidisciplinary communication and specialty referral
• Incorporate updates in clinical data to inform the identification of AD early in the disease process
• Implement SDM approaches to facilitate diagnosis and optimize management

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.

NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this enduring activity for a maximum of 1.0 ANCC contact hours.

Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Med Learning Group designates this activity for a maximum of 1.0 knowledge-based CPE contact hours.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

Commission on Dietetic Registration (CDR) Credit Designation
Med Learning Group designates this enduring activity for a maximum of 1.0 CPEU.

DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)

All relevant financial relationships have been mitigated.

Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Shannon Mutch MS, RN, OCN, has nothing to disclose.
• M. Susan Burke, MD, has nothing to disclose.
• A medical reviewer from CME Peer Review LLC has nothing to disclose.
• Chris Drury, PhD, Medical Director for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
• Andi Koral, Program Manager for Med Learning Group, has nothing to disclose.
• Daniel DaSilva, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: May 31, 2024
EXPIRATION DATE: May 31, 2025

Copyright ©2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.